Transcriptome analysis of HIV-infected peripheral blood monocytes: Gene transcripts and networks associated with neurocognitive functioning

Journal of Neuroimmunology

Volumn 265, Issue 1-2, 2013, Pages 96-105

  Levine, Andrew J ^a   Horvath, Steve ^a,b   Miller, Eric N ^a   Singer, Elyse J ^a   Shapshak, Paul ^c   Baldwin, Gayle C ^a   Martínez Maza, Otoniel ^a,d   Witt, Mallory D ^a,e   Langfelder, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Gene expression; HIV associated neurocognitive disorder; IL6R; Monocyte; Transcriptome; WGCNA

Indexed keywords

TRANSCRIPTOME;

ADULT; AGED; ARTICLE; COGNITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MITOSIS; MONOCYTE; PRIORITY JOURNAL; TRANSCRIPTION ELONGATION;

GENE EXPRESSION; HIV-ASSOCIATED NEUROCOGNITIVE DISORDER; IL6R; MONOCYTE; TRANSCRIPTOME; WGCNA;

ADULT; AGED; ANTIGENS, CD4; COGNITION DISORDERS; DEPRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; STATISTICS AS TOPIC;

EID: 84888310763     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.09.016     Document Type: Article

References (97)

1. Adle-Biassette H., Chretien F., Wingertsmann L., Hery C., Ereau T., Scaravilli F., Tardieu M., Gray F. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol. Appl. Neurobiol. 1999, 25:123-133.
2. Ancuta P., Moses A., Gabuzda D. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology 2004, 209:11-20.
3. Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Cherner M., Clifford D.B., Cinque P., Epstein L.G., Goodkin K., Gisslen M., Grant I., Heaton R.K., Joseph J., Marder K., Marra C.M., McArthur J.C., Nunn M., Price R.W., Pulliam L., Robertson K.R., Sacktor N., Valcour V., Wojna V.E. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789-1799.
4. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., Sherlock G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25:25-29.
5. Benjamini Y., Yekutieli D. Quantitative trait loci analysis using the false discovery rate. Genetics 2005, 171:783-790.
6. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 2001, 125:279-284.
7. Bian L., Yang J.D., Guo T.W., Duan Y., Qin W., Sun Y., Feng G.Y., He L. Association study of the A2M and LRP1 genes with Alzheimer disease in the Han Chinese. Biol. Psychiatry 2005, 58:731-737.
8. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
9. Borjabad A., Brooks A.I., Volsky D.J. Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. J. Neuroimmune Pharmacol. 2010, (5):44-62.
10. Brew B.J. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004, 18(Suppl. 1):S75-S78.
11. Buckner C.M., Calderon T.M., Willams D.W., Belbin T.J., Berman J.W. Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS. Cell. Immunol. 2011, 267:109-123.
12. Carlson K.A., Ciborowski P., Schellpeper C.N., Biskup T.M., Shen R.F., Luo X., Destache C.J., Gendelman H.E. Proteomic fingerprinting of HIV-1-infected human monocyte-derived macrophages: a preliminary report. J. Neuroimmunol. 2004, 147:35-42.
13. Cosenza M.A., Zhao M.L., Si Q., Lee S.C. Human brain parenchymal microglia express CD14 and CD45 and are productively infected by HIV-1 in HIV-1 encephalitis. Brain Pathol. 2002, 12:442-455.
14. Cysique L.A., Maruff P., Brew B.J. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J. Neurovirol. 2004, 10:350-357.
15. Cysique L.A., Brew B.J., Halman M., Catalan J., Sacktor N., Price R.W., Brown S., Atkinson J.H., Clifford D.B., Simpson D., Torres G., Hall C., Power C., Marder K., McArthur J.C., Symonds W., Romero C. Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J. Acquir. Immune Defic. Syndr. 2005, 39:426-429.
16. Cysique L.A., Vaida F., Letendre S., Gibson S., Cherner M., Woods S.P., McCutchan J.A., Heaton R.K., Ellis R.J. Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology 2009, 73:342-348.
17. Dore G.J., McDonald A., Li Y., Kaldor J.M., Brew B.J. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. Aids 2003, 17:1539-1545.
18. Ellery P.J., Tippett E., Chiu Y.L., Paukovics G., Cameron P.U., Solomon A., Lewin S.R., Gorry P.R., Jaworowski A., Greene W.C., Sonza S., Crowe S.M. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 2007, 178:6581-6589.
19. Fang X.X., Jiang X.L., Han X.H., Peng Y.P., Qiu Y.H. Neuroprotection of interleukin-6 against NMDA-induced neurotoxicity is mediated by JAK/STAT3, MAPK/ERK, and PI3K/AKT signaling pathways. Cell Mol. Neurobiol. 2013, 33(2):241-251. Mar.
20. Gelman B.B., Chen T., Lisinicchia J.G., Soukup V.M., Carmical J.R., Starkey J.M., Masliah E., Commins D.L., Brandt D., Grant I., Singer E.J., Levine A.J., Miller J., Winkler J.M., Fox H.S., Luxon B.A. The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS One 2012, 7:e46178.
21. Gendelman H.E., Persidsky Y., Ghorpade A., Limoges J., Stins M., Fiala M., Morrisett R. The neuropathogenesis of the AIDS dementia complex. Aids 1997, 11(Suppl. A):S35-S45.
22. Ghazalpour A., Doss S., Zhang B., Wang S., Plaisier C., Castellanos R., Brozell A., Schadt E.E., Drake T.A., Lusis A.J., Horvath S. Integrating genetic and network analysis to characterize genes related to mouse weight. PLoS Genet. 2006, 2:e130.
23. Glass J.D., Fedor H., Wesselingh S.L., McArthur J.C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 1995, 38:755-762.
24. Hans V.H., Kossmann T., Joller H., Otto V., Morganti-Kossmann M.C. Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma. Neuroreport 1999, 10:409-412.
25. Horvath S., Dong J. Geometric interpretation of gene coexpression network analysis. PLoS Comput. Biol. 2008, 4:e1000117.
26. Horvath S., Zhang B., Carlson M., Lu K.V., Zhu S., Felciano R.M., Laurance M.F., Zhao W., Qi S., Chen Z., Lee Y., Scheck A.C., Liau L.M., Wu H., Geschwind D.H., Febbo P.G., Kornblum H.I., Cloughesy T.F., Nelson S.F., Mischel P.S. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17402-17407.
27. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engel J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999, 13:76-86.
28. Janeczko K. The proliferative response of S-100 protein-positive glial cells to injury in the neonatal rat brain. Brain Res. 1991, 564:86-90.
29. Johnson W.E., Rabinovic A., Li C. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8:118-127.
30. Kang D.E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A., Thomas R.G., Thal L.J., Katzman R. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 1997, 49:56-61.
31. Kaul M., Lipton S.A. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 2006, 4:307-318.
32. Kedzierska K., Crowe S.M. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr. Med. Chem. 2002, 9:1893-1903.
33. Kim S.Y., Li J., Bentsman G., Brooks A.I., Volsky D.J. Microarray analysis of changes in cellular gene expression induced by productive infection of primary human astrocytes: implications for HAD. J. Neuroimmunol. 2004, 157:17-26.
34. Kolson D.L., Sabnekar P., Baybis M., Crino P.B. Gene expression in TUNEL-positive neurons in human immunodeficiency virus-infected brain. J. Neurovirol. 2004, 10(Suppl. 1):102-107.
35. Kounnas M.Z., Moir R.D., Rebeck G.W., Bush A.I., Argraves W.S., Tanzi R.E., Hyman B.T., Strickland D.K. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 1995, 82:331-340.
36. Kraft-Terry S.D., Buch S.J., Fox H.S., Gendelman H.E. A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 2009, 64:133-145.
37. Kuwabara K., Matsumoto M., Ikeda J., Hori O., Ogawa S., Maeda Y., Kitagawa K., Imuta N., Kinoshita T., Stern D.M., Yanagi H., Kamada T. Purification and characterization of a novel stress protein, the 150-kDa oxygen-regulated protein (ORP150), from cultured rat astrocytes and its expression in ischemic mouse brain. J. Biol. Chem. 1996, 271:5025-5032.
38. Langfelder P., Horvath S. Eigengene networks for studying the relationships between co-expression modules. BMC Syst. Biol. 2007, 1:54.
39. Langfelder P., Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinforma. 2008, 9:559.
40. Langfelder P., Zhang B., Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 2008, 24:719-720.
41. Langford T.D., Letendre S.L., Larrea G.J., Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol. 2003, 13:195-210.
42. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
43. Letendre S., Marquie-Beck J., Capparelli E., Best B., Clifford D., Collier A.C., Gelman B.B., McArthur J.C., McCutchan J.A., Morgello S., Simpson D., Grant I., Ellis R.J. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch. Neurol. 2008, 65:65-70.
44. Levine A.J., Miller J.A., Shapshak P., Gelman B., Singer E.J., Hinkin C.H., Commins D., Morgello S., Grant I., Horvath S. Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease. BMC Med. Genomics 2013, 6:4.
45. Lindl K.A., Akay C., Wang Y., White M.G., Jordan-Sciutto K.L. Expression of the endoplasmic reticulum stress response marker, BiP, in the central nervous system of HIV-positive individuals. Neuropathol. Appl. Neurobiol. 2007, 33:658-669.
46. Liu Y., Jones M., Hingtgen C.M., Bu G., Laribee N., Tanzi R.E., Moir R.D., Nath A., He J.J. Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands. Nat. Med. 2000, 6:1380-1387.
47. Luo X., Carlson K.A., Wojna V., Mayo R., Biskup T.M., Stoner J., Anderson J., Gendelman H.E., Melendez L.M. Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 2003, 60:1931-1937.
48. Marra C.M., Lockhart D., Zunt J.R., Perrin M., Coombs R.W., Collier A.C. Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology 2003, 60:1388-1390.
49. Masliah E., Roberts E.S., Langford D., Everall I., Crews L., Adame A., Rockenstein E., Fox H.S. Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J. Neuroimmunol. 2004, 157:163-175.
50. Mason M.J., Fan G., Plath K., Zhou Q., Horvath S. Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genomics 2009, 10:327.
51. McArthur J.C., Brew B.J., Nath A. Neurological complications of HIV infection. Lancet Neurol. 2005, 4:543-555.
52. Miller J.A., Cai C., Langfelder P., Geschwind D.H., Kurian S.M., Salomon D.R., Horvath S. Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinforma. 2011, 12:322.
53. Morgello S., Gelman B.B., Kozlowski P.B., Vinters H.V., Masliah E., Cornford M., Cavert W., Marra C., Grant I., Singer E.J. The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol. Appl. Neurobiol. 2001, 27:326-335.
54. Motohashi H., Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 2004, 10:549-557.
55. Oldham M.C., Horvath S., Geschwind D.H. Conservation and evolution of gene coexpression networks in human and chimpanzee brains. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17973-17978.
56. Oldham M.C., Langfelder P., Horvath S. Network methods for describing sample relationships in genomic datasets: application to Huntington's disease. BMC Syst. Biol. 2012, 6:63.
57. Otani I., Akari H., Nam K.H., Mori K., Suzuki E., Shibata H., Doi K., Terao K., Yosikawa Y. Phenotypic changes in peripheral blood monocytes of cynomolgus monkeys acutely infected with simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 1998, 14:1181-1186.
58. Ozawa K., Kondo T., Hori O., Kitao Y., Stern D.M., Eisenmenger W., Ogawa S., Ohshima T. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. J. Clin. Invest. 2001, 108:41-50.
59. Padberg F., Feneberg W., Schmidt S., Schwarz M.J., Korschenhausen D., Greenberg B.D., Nolde T., Muller N., Trapmann H., Konig N., Moller H.J., Hampel H. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. J. Neuroimmunol. 1999, 99:218-223.
60. Pedersen K.K., Pedersen M., Gaardbo J.C., Ronit A., Hartling H.J., Bruunsgaard H., Gerstoft J., Ullum H., Nielsen S.D. Persisting inflammation and chronic immune activation but intact cognitive function in HIV-infected patients after long term treatment with combination antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 2013, 63(3):272-279.
61. Peluso R., Haase A., Stowring L., Edwards M., Ventura P. A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology 1985, 147:231-236.
62. Perez D.I., Gil C., Martinez A. Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. Med. Res. Rev. 2011, 31:924-954.
63. Persidsky Y., Ghorpade A., Rasmussen J., Limoges J., Liu X.J., Stins M., Fiala M., Way D., Kim K.S., Witte M.H., Weinand M., Carhart L., Gendelman H.E. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 1999, 155:1599-1611.
64. Persidsky Y., Zheng J., Miller D., Gendelman H.E. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J. Leukoc. Biol. 2000, 68:413-422.
65. Pulliam L., Clarke J.A., McGrath M.S., Moore D., McGuire D. Monokine products as predictors of AIDS dementia. AIDS 1996, 10:1495-1500.
66. Pulliam L., Gascon R., Stubblebine M., McGuire D., McGrath M.S. Unique monocyte subset in patients with AIDS dementia. Lancet 1997, 349:692-695.
67. Pulliam L., Sun B., Rempel H. Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J. Neuroimmunol. 2004, 157:93-98.
68. Pulliam L., Rempel H., Sun B., Abadjian L., Calosing C., Meyerhoff D.J. A peripheral monocyte interferon phenotype in HIV infection correlates with a decrease in magnetic resonance spectroscopy metabolite concentrations. AIDS 2011, 25:1721-1726.
69. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385-401.
70. Ravasz E., Somera A.L., Mongru D.A., Oltvai Z.N., Barabasi A.L. Hierarchical organization of modularity in metabolic networks. Science 2002, 297:1551-1555.
71. Roberts E.S., Zandonatti M.A., Watry D.D., Madden L.J., Henriksen S.J., Taffe M.A., Fox H.S. Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am. J. Pathol. 2003, 162:2041-2057.
72. Roberts E.S., Burudi E.M., Flynn C., Madden L.J., Roinick K.L., Watry D.D., Zandonatti M.A., Taffe M.A., Fox H.S. Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS. J. Neuroimmunol. 2004, 157:81-92.
73. Robertson K.R., Smurzynski M., Parsons T.D., Wu K., Bosch R.J., Wu J., McArthur J.C., Collier A.C., Evans S.R., Ellis R.J. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007, 21:1915-1921.
74. Sacktor N., McDermott M.P., Marder K., Schifitto G., Selnes O.A., McArthur J.C., Stern Y., Albert S., Palumbo D., Kieburtz K., De Marcaida J.A., Cohen B., Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. J. Neurovirol. 2002, 8:136-142.
75. Salazar-Gonzalez J.F., Martinez-Maza O., Aziz N., Kolberg J.A., Yeghiazarian T., Shen L.P., Fahey J.L. Relationship of plasma HIV-RNA levels and levels of TNF-alpha and immune activation products in HIV infection. Clin. Immunol. Immunopathol. 1997, 84:36-45.
76. Shapshak P., Duncan R., Minagar A., Rodriguez De La Vega P., Stewart R.V., Goodkin K. Elevated expression of IFN-gamma in the HIV-1 infected brain. Front. Biosci. 2004, 9:1073-1081.
77. Shapshak P., Duncan R., Torres-Munoz J.E., Duran E.M., Minagar A., Petito C.K. Analytic approaches to differential gene expression in AIDS versus control brains. Front. Biosci. 2004, 9:2935-2946.
78. Shapshak P.D.R., Duran E.M., Farinetti F., Minagar A., Commins D., Rodriguez H., Chiappelli F., Kangueane P., Levine A.J., Singer E., Somboonwit C., Sinnott J.T. Gene expression for HIV-associated dementia and HIV encephalitis in microdissected neurons 1: preliminary analysis. Neurobehav. HIV Med. 2011, 3:53-78.
79. Shay A.H., Choi R., Whittaker K., Salehi K., Kitchen C.M., Tashkin D.P., Roth M.D., Baldwin G.C. Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine. J. Infect. Dis. 2003, 187:700-704.
80. Storey J.D., Taylor J.E., Siegmund D. Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach. J. R. Stat. Soc. Ser. B Stat. Methodol. 2004, 66:187-205.
81. Sun B., Abadjian L., Rempel H., Calosing C., Rothlind J., Pulliam L. Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection. J. Neurovirol. 2010, 16:115-124.
82. Tamatani M., Matsuyama T., Yamaguchi A., Mitsuda N., Tsukamoto Y., Taniguchi M., Che Y.H., Ozawa K., Hori O., Nishimura H., Yamashita A., Okabe M., Yanagi H., Stern D.M., Ogawa S., Tohyama M. ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat. Med. 2001, 7:317-323.
83. Tanji K., Maruyama A., Odagiri S., Mori F., Itoh K., Kakita A., Takahashi H., Wakabayashi K. Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 2013, 72:18-28.
84. Thieblemont N., Weiss L., Sadeghi H.M., Estcourt C., Haeffner-Cavaillon N. CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 1995, 25:3418-3424.
85. Tozzi V., Balestra P., Bellagamba R., Corpolongo A., Salvatori M.F., Visco-Comandini U., Vlassi C., Giulianelli M., Galgani S., Antinori A., Narciso P. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J. Acquir. Immune Defic. Syndr. 2007, 45:174-182.
86. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., Mill J., Cantor R.M., Blencowe B.J., Geschwind D.H. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
87. Warriner E.M., Rourke S.B., Rourke B.P., Rubenstein S., Millikin C., Buchanan L., Connelly P., Hyrcza M., Ostrowski M., Der S., Gough K. Immune activation and neuropsychiatric symptoms in HIV infection. J. Neuropsychiatry Clin. Neurosci. 2010, 22:321-328.
88. Wojna V., Carlson K.A., Luo X., Mayo R., Melendez L.M., Kraiselburd E., Gendelman H.E. Proteomic fingerprinting of human immunodeficiency virus type 1-associated dementia from patient monocyte-derived macrophages: a case study. J. Neurovirol. 2004, 10(Suppl. 1):74-81.
89. Yadav A., Collman R.G. CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J. Neuroimmune Pharmacol. 2009, 4:430-447.
90. Yang B., Akhter S., Chaudhuri A., Kanmogne G.D. HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling. Microvasc Res 2009, 77(2):212-219.
91. Yip A.M., Horvath S. Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinforma. 2007, 8:22.
92. Yoshioka M., Shapshak P., Srivastava A.K., Stewart R.V., Nelson S.J., Bradley W.G., Berger J.R., Rhodes R.H., Sun N.C., Nakamura S. Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 1994, 44:1120-1130.
93. Yoshioka M., Bradley W.G., Shapshak P., Nagano I., Stewart R.V., Xin K.Q., Srivastava A.K., Nakamura S. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases. Adv. Neuroimmunol. 1995, 5:335-358.
94. Zhang B., Horvath S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 2005, 4.
95. Zhang B., Horvath S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 2005, 4. (Article17).
96. Zhao L., Rosales C., Seburn K., Ron D., Ackerman S.L. Alteration of the unfolded protein response modifies neurodegeneration in a mouse model of Marinesco-Sjogren syndrome. Hum. Mol. Genet. 2010, 19:25-35.
97. Zhao J., Redell J.B., Moore A.N., Dash P.K. A novel strategy to activate cytoprotective genes in the injured brain. Biochem. Biophys. Res. Commun. 2011, 407:501-506.